Send to

Choose Destination
See comment in PubMed Commons below
Transplant Proc. 2008 Dec;40(10):3806-7. doi: 10.1016/j.transproceed.2008.09.050.

"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report.

Author information

  • 1Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany.


Fibrolamellar (FL) hepatocellular carcinoma (HCC) is a distinctive form of primary HCC that occurs principally in children and young adults. Although liver transplantation is not contraindicated for FL-HCC, noncirrhotic patients with large HCC tumors (including FL-HCCs) are not prioritized. Although hepatic resection is considered to be the primary treatment for FL-HCC, living donor liver transplantation is evolving into a potentially better alternative. Herein we have reported successful "preemptive" living donor liver transplantation for presumed recurrence of FL-HCC after an extended right hepatectomy with resection and synthetic graft replacement of the inferior vena cava.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center